The board of directors of Shanghai International Shanghai Growth Investment Limited announced that due to retirement, Dr. WANG Ching ("Dr. WANG") has resigned as an Executive Director and authorised representative under Rule 3.05 of the Rules Governing the Listing of Securities on The Stock Exchange of Hong Kong Limited (the "Listing Rules"), and ceased to be a member of the Remuneration Committee and the Investment Committee of the Company with effect from 23 March 2022. Dr. WANG has confirmed that he has no disagreement with the Board and there is no matter relating to his resignation that needs to be brought to the attention of the shareholders of the Company. The Board announced that Mr. ZHAO Tian ("Mr. ZHAO"), an Executive Director of the Company, has been appointed as the Authorised Representative of the Company under Rule 3.05 of the Listing Rules to fill the vacancy arising from the resignation of Dr. WANG with effect from 23 March 2022.

Following the resignation of Dr. WANG as an Executive Director, he has ceased to act as a member of the Company's Remuneration Committee. With effect from 23 March 2022, the Remuneration Committee comprises of Independent Non-executive Directors, namely, Mr. ONG Ka Thai (Chairman), Mr. YICK Wing Fat Simon and Dr. HUA Min, and Mr. ZHAO Tian (Executive Director). Following the resignation of Dr. WANG as an Executive Director, he has ceased to act as a member of the Company's Investment Committee.

The Board announced that Mr. CHOW Wang ("Mr. CHOW") has been appointed as a member of the Investment Committee to fill the vacancy arising from the resignation of Dr. WANG with effect from 23 March 2022. Mr. CHOW is currently one of SIAM's licensed responsible officers registered with The Securities and Futures Commission ("SFC") to carry out advising in securities (type 4) and asset management (type 9) regulated activities.